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Abstract: CYP83B1 from Arabidopsis thaliana has been identified as the oxime-metabolizing enzyme in the biosynthetic pathway of
glucosinolates. Biosynthetically active microsomes isolated from Sinapis alba converted p-hydroxyphenylacetaldoxime and cysteine into
S-alkylated p-hydroxyphenylacetothiohydroximate, S-(p-hydroxyphenylacetohydroximoyl)-L-cysteine, the next proposed intermediate in
the glucosinolate pathway. The production was shown to be dependent on a cytochrome P450 monooxygenase. We searched the genome
of A. thaliana for homologues of CYP71E1 (P450ox), the only known oxime-metabolizing enzyme in the biosynthetic pathway of the
evolutionarily related cyanogenic glucosides. By a combined use of bioinformatics, published expression data, and knock-out phenotypes,
we identified the cytochrome P450 CYP83B1 as the oxime-metabolizing enzyme in the glucosinolate pathway as evidenced by characterization of the recombinant protein expressed in Escherichia coli. The data are consistent with the hypothesis that the oxime-metabolizing
enzyme in the cyanogenic pathway (P450ox) was mutated into a “P450mox” that converted oximes into toxic compounds that the plant
detoxified into glucosinolates.

Glucosinolates are naturally occurring amino acid-derived S-glucosides of thiohydroximate-O-sulfonates. They co-occur with endogenous thioglucosidases called myrosinases that upon tissue damage
hydrolyze glucosinolates into a wide range of degradation products
such as e.g. isothiocyanates, nitriles, and thiocyanates. Glucosinolates (or rather their degradation products) are involved in plant defense and constitute characteristic flavor compounds and cancer-preventive agents in Brassica vegetables.
The biosynthetic pathway from precursor amino acid to the core
glucosinolate structure has been well studied, and many of the intermediates are known, including oximes, thiohydroximic acids, and
desulfoglucosinolates (1, 2). Recently, it has been shown that cytochromes P450 belonging to the CYP79 family catalyze the conversion of amino acids to oximes (3–7). Little is known about the formation of thiohydroximic acids from oximes. The remaining part of the
pathway for the core structure involves a UDP-glucose:thiohydroximic acid glucosyltransferase and a sulfotransferase (for review, see
Ref. 2).
It has been proposed that aci-nitro compounds are intermediates
in the conversion of oximes to thiohydroximic acids (8). This was
supported by isolation of 1-nitro-2-phenylethane from Tropaeolum
majus shoots and by in vivo conversion of phenylacetaldoxime into
1-nitro-2-phenylethane and of 1-nitro-2-[1,2-14C]phenylethane into
benzylglucosinolate (9). The aci-nitro is proposed to be conjugated
with a sulfur donor to produce an S-alkyl thiohydroximate, possibly
by a glutathione S-transferase (2). Biochemical studies indicate that
the S-alkyl thiohydroximate is subsequently hydrolyzed to the thiohydroximic acid by a C-S lyase (10).
Glucosinolates are related to cyanogenic glucosides because both
groups of natural plant products are derived from amino acids and

have oximes as intermediates. This suggests that the oxime-metabolizing enzyme is the branching point between the cyanogenic glucoside and the glucosinolate pathway. In the biosynthetic pathway
of the tyrosine-derived cyanogenic glucoside dhurrin from Sorghum
bicolor, the oxime-metabolizing enzyme (designated P450ox or
CYP71E1) catalyzes the conversion of oxime to α-hydroxynitrile by
dehydrating the oxime to a nitrile, which is then C-hydroxylated to
form the β-hydroxynitrile (11, 12).
We have previously used Sinapis alba as a model plant for biosynthetic studies of the glucosinolate pathway (13). The tyrosinederived p-hydroxybenzylglucosinolate is the major glucosinolate in
S. alba. In the present study, we characterize biochemically the oxime-metabolizing enzyme in microsomes from S. alba and show that
the enzyme is dependent on a cytochrome P450 monooxygenase. In
addition, we show that CYP83B1 is the oxime-metabolizing enzyme
in glucosinolate biosynthesis in Arabidopsis thaliana as evidenced
by biochemical characterization of the recombinant protein. The data
substantiate the results recently obtained with the rnt1-1 CYP83B1
knock-out mutant (29).

EXPERIMENTAL PROCEDURES
Chemical Synthesis
S-(Benzohydroximoyl)-L-cysteine—N-Chlorosuccinimide (280 g, 21 mmol)
and HCl gas (40 ml) were added to benzaldoxime (2.42 g, 20.0 mmol) in dimethylformamide (40 ml) and stirred at room temperature for 4 h. Water (150 ml) was
added, and the reaction mixture was extracted with diethyl ether (3 × 50 ml).
The combined ether phases were washed with water (2 × 50 ml), dried, and concentrated in vacuo. The residue oil containing the benzohydroximic acid chloride was dissolved in ethanol (50 ml) and added to a solution of ice-cold L-cys-
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teine (3.15 g, 20.0 mmol) in ethanol (100 ml). The mixture was treated with
sodium methoxide (sodium 0.74 g, 32.2 mmol; methanol 50 ml) and left stirring
for 3 h. The white precipitate was filtered, and the filtrate was concentrated in
vacuo, washed in water, and dried (3.42 g, 71%). NMR in D2O/NaOD: 1H δ 7.47.5 (5H, m, Ph), 3.28 (1H, dd, J 8.3, 3.9 Hz, CH), 2.85 (1H, dd, J 13.2, 8.3 Hz,
CH2), 3.13 (1H, dd, J = 13.2, 3.9 Hz, CH2); 13C: δ 168.4 (COOH), 150.9 (SC=N), 133.7, 128.4, 128.4, 129.1 (Ph), 53.3 (CH), 52.7 (CH2). MS1: [M + Na]+
at m/z 263, [M + H]+ at m/z 241, fragment ions at m/z 224, m/z 195, m/z 154, and
m/z 120. After a few hours in methanol, the product underwent cyclization with
concomitant release of hydroxylamine to produce (R)-2-phenyl-thiazoline-4-carboxylic acid. NMR (Me2SO-d6): 1H δ 7.4-7.8 (5H, m, Ph), 5.17 (1H, t, J 9 Hz,
CH), 3.62 (2H, d, J 9 Hz, CH2); 13C: δ 172.6 (S-C=N), 167.7 (COOH), 133.0
131.7 128.3 128.9 (Ph), 80.2 (CH), 35.7 (CH2). MS: [M + H]+ at m/z 208, fragment ion at m/z 162.
S-(Benzohydroximoyl)-N-acetyl-L-cysteine—Benzohydroximic acid chloride (1.55 g, 10 mmol) diluted with tetrahydrofuran was added dropwise to
ice-cold N-acetyl-L-cysteine (1.63 g, 10 mmol) in tetrahydrofuran (30 ml) with
triethylamine (4.04 g, 0.04 mmol). After stirring for an additional 30 min, dilute sulfuric acid (5% v/v, 100 ml) was added, the tetrahydrofuran was removed in vacuo, and the aqueous layer was left at room temperature for 48 h.
The white precipitate was filtered, and the filtrate was washed in diethyl ether
and dried (2.06 g, 73%). NMR (D2O, NaOD): 1H: d 1.95 (3H, s, CH3CO),
2.98 (1H, dd, J 5.0, 14.0, CHaHbCH), 3.00 (1H, dd, J 5.0, 14.0, CHaHbCH),
4.17 (1H, t, J 5.0, CHaHbCH) 7.40-7.49 (5H, m, 5× ArH), 13C: d 24.8 (COCH3),
35.1 (CH2), 57.6 (CH), 131.4 (2× CH), 131.5 (CH), 131.6 (2× CH), 137.0 (Cq),
155.3 (C=NOH), 175.8 (CO), 179.2 (CO). MS: [M + Na]+ at m/z 305, [M + H]+
at m/z 283, fragment ions at m/z 208, m/z 162, and m/z 130.
Preparation of Microsomal Enzyme System from S. alba
Seeds of S. alba were germinated in darkness and jasmonate-treated as
previously described (13). The preparation of microsomes was done as previously described (13) except that the isolation buffer was modified to consist of
250 mM Tricine, 100 mM ascorbic acid, 2 mM EDTA, and 2 mM dithiothreitol,
pH 8.2. The same procedure was used to prepare microsomes from seedlings of
T. majus, S. bicolor, and Zea mays.
Measurements of Oxime-metabolizing Enzyme Activities in
Microsomes from S. alba
[U-14C]p-Hydroxyphenylacetaldoxime was produced enzymatically by
CYP79A1 as previously described (14). In a typical enzyme assay, 1 mg of microsomal protein was incubated in buffer containing 30 mM KPi, pH 7.9, 3 mM
NADPH, 38 nCi (66 pmol) of [U-14C]p-hydroxyphenylacetaldoxime, and 6 mM
cysteine or N-acetylcysteine in a total volume of 200 μl. After incubation at
29 °C for 1 h, the reaction mixtures were extracted twice with 400 μl of ethyl acetate. If N-acetylcysteine was used as a sulfur donor, the remaining water phases
were acidified by addition of 200 μl of 1% formic acid and extracted three times
with 800 μl of ethyl acetate. The ethyl acetate phases were combined and dried
in vacuo. The extracts were redissolved in 30 μl of 50% ethanol and analyzed by
TLC. If cysteine was used as a sulfur donor 400 μl of 96% ethanol were added
to the remaining water phases, and the solution was clarified by centrifugation
for 15 min at 20,000 × g. The supernatants were concentrated in vacuo, redissolved in 30 μl of 50% ethanol, and analyzed by TLC. Boiled microsomes were
used in control assays. For analysis of the effect of treatment with cytochrome
P450 inhibitor, standard microsomal reaction mixtures were incubated in the
presence of 0.1 mM tetcyclasis. The TLC was performed on Silica Gel 60 F254
sheets (Merck) using 2-propanol:ethyl acetate:water (7:1:2, v/v) as eluent. The
TLC plates were eluted twice to improve separation. Radiolabeled bands were
visualized and quantified on a STORM 840 PhosphorImager (Molecular Dynamics, Sunnyvale, CA). For LC-MS analysis, 5 × 200 μl of reaction mixtures
were made as described above except that [U-14C]p-hydroxyphenylacetaldoxime was exchanged for 3 mM unlabeled oxime. The compounds were extracted
from the reaction mixtures as described above.
LC-MS Analysis
Electrospray ionization LC-MS analysis was done on a HP1100 LC coupled
to a Bruker Esquire-LC ion trap mass spectrometer. The reversed-phase LC conditions were as follows: column: XTerra MS C18 3.5 μm, 2.1 × 100 mm (Waters
Corp.); mobile phases A: 0.03% HCOOH, B: 80% MeCN, 0.1% HCOOH. The
flow rate was 0.2 ml/min, and the gradient program was 0-2 min isocratic 5% B,
1 Abbreviations: MS, mass spectrometry; LC, liquid chromatography; EST, expressed sequence tag; PCR, polymerase chain reaction.
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2-30 min linear gradient 5-100% B, and 30-35 min isocratic 100% B. The mass
spectrometer was run in positive ion mode using a low sampling cone voltage
to minimize fragmentation. Authentic standards of S-(benzohydroximoyl)-L-cysteine and S-(benzohydroximoyl)-N-acetyl-L-cysteine were synthesized and used
to develop conditions for the recording of mass spectra of analogue compounds
(see above).
Phylogenetic Trees
The protein sequences of all the members of the CYP71 family were corrected for prediction errors, and the full-length sequences were aligned including
one member of each of the families CYP76, CYP98, and CYP84 using ClustalW
(15). Phylogenetic analysis was performed with the Protdist and Fitch (FitchMargoliash and least squares method) programs of the Phylip package (16).
Generation of the Constructs for Escherichia coli Expression
The ESTs 226P8T7, 5G6, and 148G2T7 (Arabidopsis Biological Resource
Center, Columbus, OH), which encode the full-length sequences of CYP71B6,
CYP71B7, and CYP83B1, respectively, were expressed heterologously in E. coli
using the pSP19 g10L expression vector (17). Silent mutations were introduced
to enrich for A and T in the first 11 codons (17). The coding region of CYP71B6
was amplified from the EST 226P8T7 by PCR with primer 1 (sense direction;
5’-GGAATTCCATATGTCACTTTTATCTTTCCCCATT-3’) and primer 2 (antisense direction; 5’-GGCTGCAGGCATGCTTAAAGCTTGCGGTTGATGA3’). The PCR was set up in a total volume of 100 μl in Pwo polymerase PCR
buffer with 2 mM MgSO4 using 4 units of Pwo polymerase (Roche Molecular Biochemicals), 1.3 μg of template DNA, 200 μM dNTPs, and 100 pmol of
each primer. The PCR was incubated for 2 min at 94 °C, 21 cycles of 15 s at
94 °C, 20 s at 56 °C, and 70 s at 72 °C. The PCR fragment was digested with
EcoRI and PstI, ligated into pBluescript II SK (Stratagene), and transferred from
pBluescript II SK to an NdeI/SphI-digested pSP19 g10L vector. The CYP71B7
gene was PCR-amplified from EST 5G6 using primer 3 (sense direction; 5’GGAATTCATATGGCTATCTTGCTCTGTTTC-3’) and primer 4 (antisense direction; 5’-CGGGATCCCATGATCGTCATCTTAATGATG-3’). The PCR was
set up as described above. The PCR was incubated for 2 min at 94 °C, 23 cycles of 15 s at 94 °C, 45 s at 55 °C, and 2 min at 72 °C. The PCR product was
digested with EcoRI and BamHI, ligated into pBluescript II SK, and transferred from pBluescript II SK into an NdeI/BamHI-digested pSP19 g10L. The
CYP83B1 coding region was amplified from the EST 148G2T7 by PCR with
primer 5 (sense direction; 5’-GGAATTCCATATGAAACTCTTATTGATTATAGCTGGTTTAGTTGCGGCTGCAG-3’) and primer 6 (antisense direction; 5’-CGGGATCCATTAGATGTGTTTCGTTGGTGC-3’). The PCR was set
up as described above. The PCR was incubated for 2 min at 94 °C, 22 cycles
of 15 s at 94 °C, 20 s at 57 °C, and 70 s at 72 °C. The PCR fragment was digested with EcoRI and BamHI, ligated into pBluescript II SK, and transferred
from pBluescript II SK to a NdeI/BamHI-digested pSP19 g10L vector. All constructs were sequenced to exclude PCR errors.
Expression in E. coli
E. coli cells of strain C43(DE3) (18) were transformed with the expression
constructs and grown overnight in LB medium supplemented with 100 μg ml–
1 ampicillin. 2 ml of culture was used to inoculate 200 ml of modified TB medium containing 50 μg ml–1 ampicillin (14). The cultures were grown at 37 °C at
250 rpm until A600 = 0.5-0.7. Then 1 mM thiamine and 75 μg ml–1 δ-aminolevulinic acid were added, and after an additional 1 h of growth, the cultures were
induced with 1 mM isopropyl-β-D-thiogalactoside and subsequently grown at
28 °C for 40 h at 125 rpm. Spheroplasts were prepared as previously described
(14) except that glycerol was omitted in the final buffer. The amount of expressed functional cytochrome P450 was monitored by Fe2+·CO versus Fe2+ difference spectroscopy and quantified using an extinction coefficient of 91 mM–
1 cm–1.
Characterization of Enzyme Activity of Recombinant CYP71B6, CYP71B7, and
CYP83B1
The enzyme activity of CYP71B6, CYP71B7, and CYP83B1 was measured in reaction mixtures in which spheroplasts of E. coli transformed with the
respective expressing construct were reconstituted with recombinant NADPH:
cytochrome P450 reductase (ATR1) from A. thaliana. In a typical enzyme assay, 25 μl of spheroplasts and 0.06 units of NADPH:cytochrome P450 reductase
were incubated in buffer containing 50 mM Tricine, pH 8.1, 3 mM NADPH,
38 nCi (66 pmol) of [U-14C]p-hydroxyphenylacetaldoxime, and 6 mM cysteine or N-acetylcysteine in a total volume of 100 μl. Spheroplasts of E. coli
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Figure 1. Production of the cysteine conjugate (cys.cj.), the N-acetylcysteine
conjugate (N-Ac-cys.cj.), and an unidentified compound (X) by S. alba microsomes. [U-14C]p-Hydroxyphenylacetaldoxime was incubated with microsomes
from S. alba in the presence of cysteine (columns 1-5) or N-acetylcysteine (columns 6-10) as a sulfur donor. The reaction mixtures were extracted with ethyl acetate, and the water phases were analyzed by TLC. As a control boiled microsomes
were used (columns 4 and 9). In the absence of a sulfur donor a compound (X) accumulated (columns 1 and 6). The production of the conjugates was inhibited by
the cytochrome P450 inhibitor tetcyclasis (columns 5 and 10).

Figure 2. LC-MS analysis of S-(benzohydroximoyl)-L-cysteine. A, LC-MS
analysis of S-(benzohydroximoyl)-L-cysteine (I) dissolved in methanol. The total
ion chromatogram shows the starting material as Peak a and the pre-injection cyclized product, (R)-2-phenyl-thiazoline-4-carboxylic acid (II) as Peak b. The rising
baseline between the two peaks stems from on-column cyclization. B, mass spectrum of Peak a: I gives rise to the ions [M + Na]+ at m/z 263 and [M + H]+ at m/
z 241. C, mass spectrum of Peak b: II gives rise to the ion [M + H]+ at m/z 208. D,
scheme illustrating the cyclization process of S-(benzohydroximoyl)-L-cysteine to
(R)-2-phenyl-thiazoline-4-carboxylic acid.

C43(DE3) transformed with empty vector were used as controls. After incubation at 29 °C for 1 h, the reaction mixtures were extracted and analyzed as described for the microsomal assays. Product formation from the oxime was linear
with time within the first 10 min of incubation. For kinetic analysis, 5-50 μM phydroxyphenylacetaldoxime was added to the standard reaction mixture, which
was incubated for 5 min and analyzed by TLC as described above. Radiolabeled
bands were visualized and quantified on a STORM 840 PhosphorImager. For
LC-MS analysis, 10 reactions of 100 μl were done as described above except
that radiolabeled p-hydroxyphenylacetaldoxime was exchanged with 3 mM unlabeled oxime.

tate, the cysteine-dependent compound remained in the water phase,
whereas the oxime accumulated in the ethyl acetate phase. The water
solubility indicated that the cysteine-dependent compound contained
the polar groups of cysteine. The characteristics were consistent with
the compound being the proposed intermediate S-(p-hydroxyphenylacetohydroximoyl)-L-cysteine, also referred to as cysteine conjugate.
Such cysteine conjugates undergo cyclization with concomitant release of hydroxylamine to produce the corresponding 2-substituted
thiazoline-4-carboxylic acids as evidenced by the chemically synthesized authentic standard S-(benzohydroximoyl)-L-cysteine (Figure 2).
The cyclization product (R)-2-(p-hydroxybenzyl)-thiazoline-4-carboxylic acid formed from S-(p-hydroxyphenylacetohydroximoyl)-Lcysteine with [M + H]+ at m/z 238 was identified by LC-MS (Figure
3, A and B). In the presence of tetcyclasis, an inhibitor of cytochrome
P450, the production of cysteine conjugate was significantly reduced
(Figure 1, column 5). This indicated that the oxime-metabolizing enzyme in the glucosinolate pathway is a cytochrome P450-dependent
monooxygenase.
When N-acetylcysteine was used as a sulfur donor in the microsomal reaction mixtures containing [U-14C]p-hydroxyphenylacetaldoxime and NADPH, an N-acetylcysteine-dependent compound was
produced as evidenced on TLC (Figure 1, column 7). The N-acetylcysteine-dependent compound was not present when boiled microsomes were used (Figure 1, column 9), and the product formation
was significantly reduced when NADPH was not added to the reaction mixture (Figure 1, column 8), showing that the reaction was
enzyme-dependent and the electron source was NADPH. The production was inhibited by tetcyclasis as was seen for the cysteine
conjugate compound (Figure 1, column 10). The N-acetylcysteinedependent compound was identified by LC-MS analysis as S-(p-hydroxyphenylacetohydroximoyl)-N-acetyl-L-cysteine, also referred
to as N-acetylcysteine conjugate (Figure 3, C and D). In contrast to
the cysteine conjugate, no cyclization of the N-acetylcysteine conjugate took place, reflecting that the nucleophilic property of the amine
(cysteine) is considerably greater than that of the amide (N-acetylcysteine). Rearrangement, as shown in Figure 2D, can only take place if

Substrate Binding Spectra
Substrate binding spectra were measured for recombinant CYP83B1 using partially purified enzyme. Purification was obtained by temperature-induced Triton X-114 phase partitioning of E. coli spheroplasts as previously described (14). The substrate binding spectra were performed on an SLM Aminco
DW-2000 TM spectrophotometer (SLM Instruments, Urbana, IL) at 12 °C using 10 μl of the Triton X-114-rich phase in 990 μl of 50 mM KPi, pH 7.5, and
0.2 mM of either p-hydroxyphenylacetaldoxime, p-hydroxyphenylacetonitrile,
1-nitro-2-(p-hydroxyphenyl)ethane, or p-hydroxyphenylacetamide.

RESULTS
Characterization of the Oxime-metabolizing Enzyme in Microsomes from S. alba—Biosynthetically active microsomes from S. alba
seedlings were isolated under conditions where myrosinase was inhibited to prevent formation of inhibitory breakdown products from
the glucosinolates in the tissue (13). When [U-14C]p-hydroxyphenylacetaldoxime and cysteine were added to microsomes from S. alba
in the presence of NADPH, a cysteine-dependent radiolabeled compound accumulated in the reaction mixtures as evidenced by TLC
analysis (Figure 1, column 2). The compound was not detectable
when boiled microsomes were used (Figure 1, column 4), indicating
that the reaction required the presence of an active enzyme. The product formation was significantly reduced when NADPH was not added
to the reaction mixture, further emphasizing that the reaction was enzyme-dependent and the electron source was NADPH (Figure 1, column 3). When the reaction mixtures were extracted with ethyl ace-
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Figure 4. A phylogenetic tree of the CYP71 family in A. thaliana and
CYP71E1 (P450ox) from S. bicolor. The tree was constructed by alignment of the
amino acid sequences using ClustalW. Phylogenetic analysis was performed with
the Protdist and Fitch (Fitch-Margoliash and least squares method) programs of the
Phylip package. Despite their original name, the CYP83s belong correctly to the
CYP71 family. CYP76C4, CYP98A3, and CYP84A1 are included as outgroups.
CYP71B7, CYP71B6, and CYP83B1 were tested earlier as candidates for the oxime-metabolizing enzyme in the glucosinolate pathway.

Figure 3. Identification by LC-MS of (R)-2-(p-hydroxybenzyl)-thiazoline-4carboxylic acid and of S-(p-hydroxyphenylacetohydroximoyl)-N-acetyl-L-cysteine produced by S. alba microsomes. A, reconstructed ion chromatogram of
m/z 238. B, mass spectrum of the cyclization product (R)-2-(p-hydroxybenzyl)thiazoline-4-carboxylic acid of S-(p-hydroxyphenylacetohydroximoyl)-L-cysteine showing [M + H]+ at m/z 238 and fragment ion at m/z 107. C, reconstructed
ion chromatogram (m/z 313) showing the E- and Z-isomers of the product S-(phydroxyphenylacetohydroximoyl)-N-acetyl-L-cysteine (I) and reconstructed ion
chromatogram (m/z 152) showing E- and Z-isomers of the substrate p-hydroxyphenylacetaldoxime (II). D, mass spectrum of S-(p-hydroxyphenylacetohydroximoyl)-N-acetyl-L-cysteine showing [M + Na]+ at m/z 335, [M + H]+ at m/z 313, and
fragment ions at m/z 162, 130, and 107.

the N-acetyl group is eliminated; this was not seen over the time
course of the reaction. It may take place, however, if the reaction
is allowed to proceed for a longer period of time during which hydrolysis occurs. By the LC-MS analysis of the N-acetylcysteine conjugate two peaks were seen at retention times of 12.9 and
14.6 min corresponding to the E- and Z-isomers of the hydroximino
group of the molecule, respectively. The two isomers had identical
mass spectra with [M + Na]+ at m/z 335, [M + H]+ at m/z 313, and
fragments at m/z 162, 130, and 107 (Figure 3D). Very low sampling cone voltage was required for detection of the molecular ion.
The conditions for detecting the molecular ion were developed using the authentic standards S-(benzohydroximoyl)-L-cysteine and
S-(benzohydroximoyl)-N-acetyl-L-cysteine.

When [U-14C]p-hydroxyphenylacetaldoxime and NADPH
were added to microsomes from S. alba in the absence of a sulfur
donor, a radiolabeled compound (X) accumulated in the reaction
mixtures as evidenced by TLC (Figure 1, columns 1 and 6). The ac-

cumulation of this product (X) was reduced when a sulfur donor was
added (Figure 1, columns 2 and 7). Another compound accumulated
in low amounts in ethyl acetate extracts of the reaction mixtures (data
not shown). The compound co-migrated with authentic 1-nitro-2-(phydroxyphenyl)ethane. The identity of the compound was confirmed
by gas chromatography-MS (data not shown). The specificity of the
oxidation of oxime to nitro for the glucosinolate biosynthetic pathway was investigated by testing the ability of microsomes isolated
from another glucosinolate-producing plant (T. majus) and a non-glucosinolate-producing plant (Z. mays) to produce the nitro compound.
Both T. majus and maize were able to convert the p-hydroxyphenylacetaldoxime into 1-nitro-2-(p-hydroxyphenyl)ethane, showing that
the reaction is not specific for glucosinolate-producing plants.
Phylogenetic Analysis— The activity of the oxime-metabolizing
enzyme in microsomes in S. alba was too low to pursue a biochemical approach to identify the cytochrome P450 involved, which we for
evolutionary reasons expected to be related to the oxime-metabolizing
enzyme in the cyanogenic pathway. Considering the rapid advance
of the genome-sequencing project of A. thaliana, we took a bioinformatics approach to search for homologues of CYP71E1 (P450ox),
which presently is the only oxime-metabolizing enzyme identified in
the biosynthetic pathway of cyanogenic glucosides (12). In addition
to the cytochromes designated CYP71s, members of the CYP83 family belong correctly to the CYP71 family based on sequence similarity.2 With the sequences available at the given time (summer/autumn
1999), we combined BLAST searches and sequence alignments, expression data (19), and mutant phenotypes (20)3 to identify candidates for the oxime-metabolizing enzyme in A. thaliana. Among the
candidate genes found in the closest related subfamilies, CYP71B7,
2
3

S. Paquette and S. Bak, personal communication.
S. Bak, personal communication.
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Figure 5. Carbon monoxide difference spectra of CYP71B7 and CYP83B1.
The Fe2+·CO versus Fe2+ difference spectra were measured on spheroplasts of
E. coli expressing CYP71B7, CYP83B1, or empty vector. The spectra were recorded at 12 °C.

CYP71B6, and CYP83B1 existed as full-length ESTs and were expressed in E. coli. After completion of the genome-sequencing project of A. thaliana, a phylogenetic tree of the CYP71 family was made
(Figure 4).
Heterologous Expression of CYP71B6, CYP71B7, and CYP83B1
in E. coli— CYP71B6, CYP71B7, and CYP83B1 were expressed in
E. coli strain C43(DE3) by use of the expression vector pSP19 g10L.
CO difference spectrum with the characteristic peak at 450 nm was
obtained for CYP71B7 and CYP83B1 indicating the presence of
functional cytochrome P450 (Figure 5). Based on the peak at 450 nm,
the expression levels of CYP71B7 and CYP83B1 were estimated to
be 50 and 430 nmol of cytochrome P450 (liter of culture) 1, respectively. The expression of CYP71B6 in E. coli did not result in production of a protein giving a peak at 450 nm in a CO difference spectrum; this, however, does not exclude the presence of a functional
protein (4). When [U-14C]p-hydroxyphenylacetaldoxime and cysteine or N-acetylcysteine were added to spheroplasts of E. coli expressing CYP83B1 reconstituted with NADPH:cytochrome P450 reductase in the presence of NADPH, a compound accumulated in the
reaction mixtures that co-migrated with the cysteine conjugate (Figure 6, column 4) and the N-acetylcysteine conjugate (Figure 6, column 9) produced by the S. alba microsomes as evidenced by TLC.
Formation of these products was furthermore shown to be dependent on NADPH as the electron source (Figure 6, columns 5 and
10). The products were not detected in reaction mixtures containing E. coli spheroplasts harboring either the CYP71B6 or CYP71B7
(data not shown) or empty vector (Figure 6, columns 1 and 6). The
compounds produced from p-hydroxyphenylacetaldoxime by recombinant CYP83B1 using cysteine or N-acetylcysteine as a sulfur donor were identified by LC-MS analysis as the cyclization product of
S-(p-hydroxyphenylacetohydroximoyl)-L-cysteine or the (uncyclizing) S-(p-hydroxyphenylacetohydroximoyl)-N-acetylcysteine (data
not shown), respectively. Recombinant CYP83B1 has a pH optimum
of 8.1, and kinetic studies showed that it has a turnover number of
16 min–1 and a Km of 68 μM for p-hydroxyphenylacetaldoxime.
When radiolabeled oxime and NADPH were incubated with
recombinant CYP83B1 in the absence of a sulfur donor, a radiolabeled compound accumulated in the reaction mixture that comigrated with the unidentified compound that accumulated in
the S. alba microsomal reaction mixtures under the same conditions as evidenced by TLC (Figure 6, columns 3 and 8). Several attempts to identify the compound (X) were unsuccessful. Accumulation of the unidentified product (X) and of radiolabeling retained
at the application site was greatly reduced when a sulfur donor was
added (Figure 6, columns 4 and 9). No detectable amounts of 1-nitro-2-(p-hydroxyphenyl)ethane accumulated in the reaction mixtures

Figure 6. Production of the cysteine conjugate (cys.cj.), the N-acetylcysteine conjugate (N-Ac-cys.cj.), and an unidentified compound (X) by CYP83B1
(83B1). [U-14C]p-Hydroxyphenylacetaldoxime was incubated with recombinant
CYP83B1 reconstituted with NADPH:cytochrome P450 reductase in the presence
of cysteine (columns 2-5) or N-acetylcysteine (columns 7-10) as a sulfur donor.
The reaction mixtures were extracted with ethyl acetate, and the water phases were
analyzed by TLC. In the absence of a sulfur donor a compound (X) accumulated
(columns 3 and 8). Empty vector was used as a control (c) (columns 1 and 6).

containing recombinant CYP83B1. Furthermore, neither 1-nitro-2(p-hydroxyphenyl)ethane nor p-hydroxyphenylacetonitrile was metabolized by CYP83B1 (data not shown). This indicates that neither
the nitro compound nor nitrile is involved in the reaction catalyzed
by CYP83B1.
Substrate Binding to CYP83B1— We analyzed spectrally the
binding of substrate and potential intermediates to CYP83B1. Recombinant CYP83B1 was partially purified from E. coli spheroplasts by temperature-induced phase partitioning, which produced
a detergent rich-phase containing the majority of the cytochrome
P450. Recombinant CYP83B1 produced a type I spectrum with p-hydroxyphenylacetaldoxime (λmax 390 nm and λmin 427 nm), p-hydroxyphenylacetonitrile (λmax 391 nm and λmin 427 nm), and 1-nitro-2-(phydroxyphenyl)ethane (λmax 391 nm and λmin 427 nm) indicating a
shift from a low to a high spin state upon substrate binding (21) (Figure 7, a, b, and c). The amplitude increased in size upon incubation
and reached a stable maximum after ~30 min. No substrate binding
spectrum was obtained upon the addition of p-hydroxyphenylacetamide (data not shown). Although neither the nitrile nor nitro compound was metabolized by CYP83B1, the formation of type I binding
spectra demonstrated that CYP83B1 was able to bind these analogues.

DISCUSSION
In the present study, we have characterized biochemically the
conversion of p-hydroxyphenylacetaldoxime to S-(p-hydroxyphenylacetohydroximoyl)-L-cysteine in microsomes from S. alba and shown
that the enzyme activity was dependent on a cytochrome P450 monooxygenase. By combined use of bioinformatics, published expression data, and knock-out phenotypes, we identified CYP83B1 as the
oxime-metabolizing enzyme in the glucosinolate pathway. We have
used the tyrosine-derived oxime as substrate, although A. thaliana
does not produce the tyrosine-derived p-hydroxybenzylglucosinolate.
We have, however, previously shown that A. thaliana is capable of
converting p-hydroxyphenylacetaldoxime into p-hydroxybenzylglucosinolate (22).

CYP83B1

AS OXIME - METABOLIZING ENZYME IN

A RABIDOPSIS

Figure 7. Substrate binding spectra obtained with recombinant CYP83B1.
Each cuvette contained 0.25 nmol of recombinant CYP83B1 partly purified into a
Triton X-114 detergent-rich phase. 0.2 mM of substrate was added to the sample
cuvette, and spectra were recorded at 12 °C after 45 min.

S-(Hydroximoyl)-L-cysteine is the most likely S-alkyl thiohydroximate in the glucosinolate pathway for several reasons. First, in
vivo feeding studies have shown that among other sulfur donors, cysteine is most efficiently incorporated into glucosinolates (23). Second, the enzyme that converts S-alkyl thiohydroximate to thiohydroximate is likely to be a C-S lyase, and the characterized C-S lyases
from plants hydrolyze S-substituted cysteine derivatives and have an
absolute requirement for the presence of the α-hydrogen atom and an
unsubstituted amino group in the cysteine moiety (10, 24). We have
succeeded for the first time in obtaining a mass spectrum providing
evidence for enzymatic synthesis of the proposed intermediate S-(phydroxyphenylacetohydroximoyl)-L-cysteine. In vitro S-(p-hydroxyphenylacetohydroximoyl)-L-cysteine undergoes cyclization, which
indicates that the proposed C-S lyase is tightly coupled to the sulfurconjugating enzyme in vivo.
For the oxime to be converted into the S-alkyl thiohydroximate,
it needs to be oxidized prior to conjugation with the sulfur donor. We
have shown the production of 1-nitro-2-(p-hydroxyphenyl)ethane
from p-hydroxyphenylacetaldoxime in microsomes from S. alba,
T. majus, and Z. mays. Although recombinant CYP83B1 is able to
bind the nitro to the active site, no nitro production or metabolism by
the enzyme was detected, indicating that nitro compounds are not intermediates in the glucosinolate pathway. The form of the oxidized
oxime might be the corresponding aci-nitro compounds (8) or nitrile
oxides4 (Figure 8), which are interconvertible by a simple dehydration/hydration reaction and which are very reactive compounds and
subject to nucleophilic attack by e.g. cysteine. Based on the expected
strong reactivity of the oxidized oxime, conjugation of the sulfur donor is likely to be under strict control. The proposed cysteine conjugation might be carried out by a glutathione S-transferase. Alternatively, CYP83B1 may have a binding site not only for the oxime but
also for cysteine. In the absence of added sulfur donor, an unidentified compound (X) accumulated in the reaction mixture. This compound might be a furoxan (1,2,5-oxadiazole 2-oxide) formed by dimerization of nitrile oxide, or it might be a conjugate derived from
a nucleophile present in the reaction mixture. Further studies are in
progress to elucidate the mechanism for the formation of the cysteine conjugate.
Cyanogenic glucosides and glucosinolates are related groups of
natural plant products derived from amino acids and with oximes
as intermediates. Cyanogenic glucosides occur throughout the plant
kingdom. This indicates that cyanogenesis arose as a very early evolutionary event. In contrast, glucosinolates are restricted to the order
Capparales and the genus Drypetes in the distant order Euphorbiales
(25). Cytochromes P450 belonging to the CYP79 family have been
shown to catalyze the conversion of amino acids to oximes in both
the cyanogenic and the glucosinolate pathway (3-7, 26), supporting
the speculation that the biosynthesis of glucosinolates has evolved
from the cyanogenic pathway (27).
4 A.

Kjær, personal communication.
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Figure 8. The conversion of oxime to thiohydroximic acid in the glucosinolate pathway. It is presently not known whether the oxime is oxidized to an acinitro compound or a nitrile oxide by CYP83B1.

Figure 9. The evolutionary relationship between cyanogenic glucosides and
glucosinolates. Identification of the oxime-metabolizing enzyme in the glucosinolate pathway (CYP83B1/P450mox) as related to the oxime-metabolizing enzyme
in the cyanogenic pathway (CYP71E1/P450ox) is consistent with the hypothesis that the P450ox in the cyanogenic pathway was mutated into a “P450mox”
that converted the oxime into a toxic compound that the plant detoxified into a
glucosinolate.

If evolution of glucosinolates is based on a “cyanogenic predisposition,” this raises the question of how glucosinolates evolved.
In the biosynthetic pathway of the cyanogenic glucoside dhurrin in
S. bicolor, the oxime-metabolizing enzyme P450ox (CYP71E1) converts the oxime to a α-hydroxynitrile (26). Our working hypothesis
has been that a mutated homologue of P450ox, P450mox, catalyzes
the oxime-metabolizing step in the biosynthetic pathway of glucosinolates (Figure 9). According to the hypothesis, P450mox would
oxidize the oxime to a toxic or reactive compound such as an acinitro or a nitrile oxide, which the plant subsequently would have to
detoxify. The post-oxime enzymes include the proposed glutathione S-transferase and C-S lyase in addition to the known glucosyltransferase and sulfotransferase. These enzyme groups are known to
be involved in general detoxification reactions. This makes it likely
that post-oxime enzymes have been recruited from the detoxification processes but now are specialized for glucosinolate production.
Several mutants of CYP83B1 have been reported (20, 28, 29). Recently, CYP83B1 was described as a regulator of auxin production
by controlling the flux of indole-3-acetaldoxime into indole-3-acetic
acid and indole glucosinolates (29). Characterization of recombinant
CYP83B1 expressed in yeast showed that indole-3-acetaldoxime is
a high affinity substrate for CYP83B1. The product obtained was
shown to form adducts with a number of thiol compounds (29). It has
been suggested that the glucosinolate pathway evolved from an indole-3-acetic acid biosynthetic pathway and not necessarily from the
cyanogenic pathway (29). Cyanogenic glucosides are derived from
only five protein amino acids (Tyr, Phe, Leu, Ile, and Val). The same
few protein amino acids are also precursors for glucosinolates together with tryptophan, alanine, methionine, and chain-elongated derivatives of methionine and phenylalanine, which are not precursors
of cyanogenic glucosides. This suggests that CYP79s of the glucosinolate pathway have acquired new substrate specificities after having
diverged from the “cyanogenic” CYP79s. The biosynthesis of tryptophan-derived and chain-elongated amino acid-derived glucosinolates
seems to be recent evolutionary events because indole glucosinolates
are present in only four families in the order Capparales, namely in
the Brassicaceae, Resedaceae, Tovaraceae, and Capparaceae (30),
and because glucosinolates from chain-elongated amino acids are
only found in Brassicaceae, Resedaceae, and Capparaceae (1). Considering the taxonomical distribution of cyanogenic glucosides and
glucosinolates in the plant kingdom and of indole glucosinolates in
only four families in the Capparales order (30), it appears likely that
glucosinolates have evolved from a cyanogenic predisposition.
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The CYP71 family is the largest cytochrome P450 family in
A. thaliana with 47 members that cluster into different subgroups
(Figure 4). In the Arabidopsis genome, another member of the CYP83
family, CYP83A1, with 65% identity to CYP83B1 at the amino acid
level has been identified. The high sequence similarity suggests that
CYP83A1 may be an oxime-metabolizing enzyme in the glucosinolate pathway. The two CYP83s form a little subgroup that is located
close to the CYP71E1, which is consistent with an evolutionary relationship between the oxime-metabolizing enzymes in the cyanogenic
and the glucosinolate pathway.
Within the last few years considerable advances in our understanding of glucosinolate biosynthesis have been achieved. Identification of the oxime-metabolizing enzymes in both the cyanogenic
and the glucosinolate pathways combined with identification of substrate-specific oxime-producing CYP79s provides important molecular tools for metabolic engineering of glucosinolate profiles and for
introduction of cyanogenic glucosides and other oxime-derived compounds in a glucosinolate or a non-glucosinolate background.
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